Kawasaki, Japan

Haruko Hirashima



Average Co-Inventor Count = 8.8

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Haruko Hirashima: Innovator in Pharmaceutical Chemistry

Introduction

Haruko Hirashima is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of three patents to her name, Hirashima's work has garnered attention in the scientific community.

Latest Patents

Hirashima's latest patents include innovative compounds that serve as potential treatments for various medical conditions. One of her notable inventions is the "Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride." This compound is recognized for its utility as α4 integrin inhibitors. Additionally, she has developed aniline derivatives that exhibit kininogenase-inhibitory action, showcasing their pharmaceutical potential.

Career Highlights

Hirashima is currently employed at Ajinomoto Co., Ltd., where she continues to advance her research and development efforts. Her work at this esteemed company has allowed her to explore various innovative solutions in the pharmaceutical sector.

Collaborations

Hirashima has collaborated with notable colleagues, including Koichi Fujita and Shinichiro Takahashi. These partnerships have contributed to her success and the advancement of her research projects.

Conclusion

Haruko Hirashima is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of valuable compounds. Her contributions continue to impact the field positively, and her innovative spirit drives her ongoing research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…